Rare diseases
Investigational molecules
Locations
Viaduktstrasse 8, 4051
Immunovant Sciences GmbH funds clinical research in Graves’ disease, thyroid eye disease, and related thyroid hormone dysregulation, with attention to endocrine and orbital manifestations.
Its research activity also extends to maintaining euthyroidism and evaluating outcomes tied to antithyroid therapy.
Immunovant Sciences GmbH runs clinical trials in conditions such as Graves' disease, Chronic inflammatory demyelinating polyradiculoneuropathy, Endocrine ophthalmopathy, Myasthenia gravis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Long-Term Study of Imeroprubart in Adults With Graves' Disease
BelgiumA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
AustriaStudy of IMVT-1402 Treatment for Adults with Graves' Disease
BulgariaStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
CzechiaStudy on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease
BelgiumA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
GermanyStudy on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus
BulgariaStudy on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis
BulgariaStudy on the Long-term Safety of Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
GermanyStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumStudy on the Effects of Batoclimab for Patients with Graves' Disease
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
